Active BE 0782.955.294Private limited company

Biocubik

Rue du Bois St-Jean 29 ·4102 Seraing, Belgium· 4 yrs active

Sector: Speur- en ontwikkelingswerk op biotechnologisch gebied (72101)

Conclusion Checked

The computed 12-month bankruptcy probability of Biocubik is 1.0% (low). The 2025 annual accounts show equity of €500k and a net result of €-48k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 84% of 81 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Key figures

Equity	€500k
Net result	€-48k
Staff (FTE)	1.9
Better than sector	84%

Snowflake analysis 5 of 5 axes measured · computed by Checked

62 / 100

Strong profile, led by solvency.

All 5 axes are computed from data Checked has read.

Health 63

Profitability 0

Solvency 100

Growth 52

Stability 94

Bankruptcy probability (12 mo) Checked model v1 · free

1.0% Low

0%0,5%1,5%4%10%≥25%

Young company +Lower-failure-rate sector −Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 2 signals

More than 3 years active

Founded in 2022, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags 0 events

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Health barometer FY 2025 · computed

63 / 100 Healthy

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Financial overview4 NBB filings

Annual accounts filed on 11-05-2026 with the NBB · fiscal year 2025 · volledig

Operating resultNet result

Sector comparison

Fiscal year 2025 · NACE 72 · compared across all schema types (micro, abbreviated and full combined)

Metric	This company	Sector median	Position in the sector
Solvency	84.4%	49.8%	better than 84% of 81 sector peers
Net result	€-48k	€17k	better than 21% of 80 sector peers
Equity	€500k	€102k	better than 77% of 81 sector peers
Gross operating margin	€68k	€49k	better than 56% of 76 sector peers
Total assets	€593k	€250k	better than 72% of 81 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€-41k

+73.3% 22-25

Net profit

€-48k

+68.5% 22-25

Cash flow

€-42k

+72.4% 22-25

Total assets

€593k

+372.1% 22-25

Equity

€500k

+2497.9% 22-25

Working capital

€427k

+390.1% 22-25

Employees (FTE)

2

+46.2% 22-25

Staff costs

€108k

+40.1% 22-25

Income taxes

€277

+11.6% 22-25

Debt

€93k

-12.8% 22-25

Debt ≤ 1y

€80k

+137.3% 22-25

Debt > 1y

€13k

-82.8% 22-25

Current ratio

6.32

+76.8% 22-25

Quick ratio

5.01

+40.2% 22-25

Solvency

84.4%

+450.3% 22-25

Debt / equity

0.19

-96.6% 22-25

ROE

-9.6%

+98.8% 22-25

ROA

-8.1%

+93.3% 22-25

Interest coverage

-16.72

- 22-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	volledig
Revenue	-
EBITDA	€-41k
Net profit	€-48k
Cash flow	€-42k
Staff costs	€108k
Income taxes	€277
Dividends	-
Total assets	€593k
Equity	€500k
Debt	€93k
of which ≤ 1y	€80k
of which > 1y	€13k
Working capital	€427k
Employees (FTE)	1.9

Ratios (computed)

	2025
Current ratio	6.32
Quick ratio	5.01
Working capital ratio	72.1%
Solvency	84.4%
Debt / equity	0.19
Long-term debt ratio	0.02
Interest coverage	-16.72
Gross margin	-
Net margin	-
ROA	-8.1%
ROE	-9.6%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €85k · 14.4% Current assets €507k · 85.6%

Equity & liabilities

Equity €500k · 84.4% Debt €93k · 15.7%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€593k
Fixed assets	21/28	€85k
Intangible fixed assets	21	€83k
Tangible fixed assets	22/27	€2k
Current assets	29/58	€507k
Stocks & contracts in progress	3	€105k
Amounts receivable within one year	40/41	€218k
Cash & bank	54/58	€183k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€593k
Equity	10/15	€500k
Contributions / capital	10/11	€550k
Accumulated profits (losses)	14	€-329k
Amounts payable	17/49	€93k
Amounts payable after one year	17	€13k
Amounts payable within one year	42/48	€80k
Trade debts payable within one year	44	€38k
Income statement
Gross operating margin	9900	€68k
Operating result	9901	€-47k
Financial income	75	€2k
Financial charges	65	€2k
Result before taxes	9903	€-48k
Income taxes	67/77	€277
Net result for the period	9904	€-48k
Result to be appropriated	9905	€-48k

You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Legal Structure

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Private limited company(610)
Incorporation	07-03-2022
Status	Active
Postal code	4102

Establishment units 1 location

Biocubik

Rue du Bois St-Jean 29, 4102 SeraingVervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur

since 20222.330.147.856

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Updates 7 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026

11-05-2026

NBB filing Annual accounts filed

fiscal year 2025 · volledig

2025

14-05-2025

State Gazette act Capital & shares

François Catinus

25-04-2025

State Gazette act Capital & shares

François Catinus

17-03-2025

NBB filing Annual accounts filed

fiscal year 2024 · micro

2024

15-04-2024

NBB filing Annual accounts filed

fiscal year 2023 · micro

2023

08-12-2023

State Gazette act Capital & shares

François Catinus

23-03-2023

NBB filing Annual accounts filed

fiscal year 2022 · micro

Belgisch Staatsblad, acts 3 acts

Capital history · 3

14-05-2025

Capital change

25-04-2025

Capital change

08-12-2023

Capital change

All acts · 3 updated 1 year ago

2025

14-05-2025 Capital increase of €250,000 to €550,000 Capital & shares·François Catinus

€300.000 → €550.000
Inbreng in geld · Apport en numéraire

Notary: François Catinus · Bastogne

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 550000.0,
      "delta_eur": 250000.0,
      "before_eur": 300000.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "KAZOKU",
          "share_class": null,
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 2500,
          "contribution_amount_eur": 250000.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": 2500,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 250000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Fran\u00E7ois Catinus",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bastogne",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-05-14",
    "filing_date": "2025-04-23",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2025-04-24",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2025-04-23"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0782.955.294",
    "name_full": "BIOCUBIK TRIBU",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "_kbo_filled_from_list": true,
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "shareholders_after": [],
  "share_classes_after": []
}

25-04-2025 Capital increase of €250,000 to €550,000 Capital & shares·François Catinus

€300.000 → €550.000
Inbreng in geld · Apport en numéraire

Notary: François Catinus · Bastogne

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 2500,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 100.0
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 550000.0,
      "delta_eur": 250000.0,
      "before_eur": 300000.0,
      "subscribers": [
        {
          "kbo": "0787.215.475",
          "rrn": null,
          "kind": "org",
          "name": "KAZOKU",
          "share_class": null,
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 250,
          "contribution_amount_eur": 250000.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 5500,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 100.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 250000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Fran\u00E7ois Catinus",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bastogne",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-04-25",
    "filing_date": "2025-04-23",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale",
    "act_date": "2025-04-23",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": true,
    "firm_kbo": null,
    "firm_name": null,
    "ibr_number": null,
    "mission_type": null,
    "individual_name": null
  },
  "subject_company": {
    "kbo": "0782.955.294",
    "name_full": "BIOCUBIK",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "shareholders_after": [
    {
      "kbo": "0787.215.475",
      "pct": null,
      "kind": "org",
      "name": "KAZOKU",
      "role": null,
      "n_shares": 250,
      "share_class": null
    }
  ],
  "share_classes_after": []
}

2023

08-12-2023 Restructuring of share classes Capital & shares·François Catinus

Notary: François Catinus · Florenville

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": "0787.215.475",
          "rrn": null,
          "kind": "org",
          "name": "KAZOKU",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": "geld",
          "n_shares_subscribed": 2800,
          "contribution_amount_eur": 280000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "DELADRIERE Jean-Luc",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": "geld",
          "n_shares_subscribed": 100,
          "contribution_amount_eur": 10000.0
        },
        {
          "kbo": "0787.215.475",
          "rrn": null,
          "kind": "org",
          "name": "KAZOKU",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": "geld",
          "n_shares_subscribed": 1000,
          "contribution_amount_eur": 100000.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 2900,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 100.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": 3000,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Fran\u00E7ois Catinus",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Florenville",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-12-08",
    "filing_date": "2023-12-06",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2023-12-06",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2023-12-06"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0782.955.294",
    "name_full": "BIOCUBIK",
    "legal_form": "SRL",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition"
  ],
  "shareholders_after": [
    {
      "kbo": "0787.215.475",
      "pct": null,
      "kind": "org",
      "name": "KAZOKU",
      "role": null,
      "n_shares": 3800,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "DELADRIERE Jean-Luc",
      "role": null,
      "n_shares": 100,
      "share_class": null
    }
  ],
  "share_classes_after": []
}

Credit advice verdict per customer and amount

AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Company registry (CBE) Crossroads Bank

Activities

Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur26600Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur26600Ingenieurs en aanverwante technische adviseurs, exclusief landmeters71121Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts71121

Primary activity highlighted.

Names & trade names

Legal nameFR	Biocubik
AbbreviationFR	bcbk
Trade nameFR	Biocubik

Registered office

Rue du Bois St-Jean 29

4102 Seraing, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.

Similar companies Comparable size · 143 of 760 companies in this sector with filed accounts

DOKTER DRIES TANT BE 0476.525.861 · Brugge

SYNLOCK BE 0792.288.674 · Jemeppe-sur-Sambre

Xper Research BE 0803.514.247 · Oudenaarde

Groovy.Bio BE 0776.937.633 · Antwerpen

CELL-CELL BIO BE 0782.638.362 · Gent